Literature DB >> 561671

Study on the binding of dihydrotestosterone, testosterone and oestradiol with sex hormone binding globulin.

F Mean, M Pellaton, G Magrini.   

Abstract

Saturation studies on sex hormone binding globulin (SHBG) were performed with increasing levels of the three steroids: dihydrotestosterone (DHT), testosterone (T) and oestradiol (E2) in normal female sera. The curves obtained showed the clearly increasing SHBG affinity for E2, T and DHT, respectively. With T as saturating ligand, the mean values of SHBG binding capacity in normal and pathological sera, expressed as 10(-8) M SHBG were, for normal women, 5.87 +/- 0.2, for normal men, 3.69 +/- 0.1 and for hirsute women, 5.05 +/- 0.2. In hirsutism, SHBG levels were measured together with T and DHT levels. Hyperandrogenia was often better reflected by the T/SHBG ratio than by T levels alone. SHBG binding capacity, measured in pregnancy from the 7th to the 40th week, increased progressively as far as the 30th week. Values up to 5 times those of the mean value of the cycle were observed at the end of pregnancy. Variations in DHT, T and E2 binding as functions of SHBG concentrations, were also studied by adding a constant amount of each steroid to increasing SHBG concentrations in serum. DHT showed the greatest binding capacity, followed by T and then E2. Since the unbound fractions of T and DHT are believed to be biologically active, and since T and DHT are more sensitive than E2 to SHBG variations, the results obtained further support the hypothesis that SHBG plays an important role in the sex steroids balance.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 561671     DOI: 10.1016/0009-8981(77)90276-5

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  11 in total

1.  Pharmacokinetics of vancomycin in patients undergoing continuous ambulatory peritoneal dialysis.

Authors:  R D Blevins; C E Halstenson; N G Salem; G R Matzke
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

Review 2.  Endocrine disruption through membrane estrogen receptors and novel pathways leading to rapid toxicological and epigenetic effects.

Authors:  Cheryl S Rosenfeld; Paul S Cooke
Journal:  J Steroid Biochem Mol Biol       Date:  2018-11-19       Impact factor: 4.292

3.  Homozygous SHBG Variant (rs6258) Linked to Gonadotropin-Independent Precocious Puberty in a Young Girl.

Authors:  Victoria C Andriessen; Marissa Lightbourne; Chelsi Flippo; Fabio R Faucz; Angela Delaney; Fady Hannah-Shmouni; Geoffrey L Hammond; Constantine A Stratakis
Journal:  J Endocr Soc       Date:  2021-07-19

4.  A 7-week follow-up study of the behaviour of testosterone and cortisol during the competition period in rowers.

Authors:  A Urhausen; T Kullmer; W Kindermann
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1987

5.  Four weeks of androstenedione supplementation diminishes the treatment response in middle aged men.

Authors:  S G Beckham; C P Earnest
Journal:  Br J Sports Med       Date:  2003-06       Impact factor: 13.800

Review 6.  Non-genomic actions of androgens.

Authors:  C D Foradori; M J Weiser; R J Handa
Journal:  Front Neuroendocrinol       Date:  2007-11-07       Impact factor: 8.606

7.  Detection of genetic variation with radioactive ligands. V. Genetic variants of testosterone-binding globulin in human serum.

Authors:  A Luckock; L L Cavalli-Sforza
Journal:  Am J Hum Genet       Date:  1983-01       Impact factor: 11.025

8.  Dietary beta-tocopherol and linoleic acid, serum insulin, and waist circumference predict circulating sex hormone-binding globulin in premenopausal women.

Authors:  Fatima Nayeem; Manubai Nagamani; Karl E Anderson; Yafei Huang; James J Grady; Lee-Jane W Lu
Journal:  J Nutr       Date:  2009-04-01       Impact factor: 4.798

9.  SHBG141-161 Domain-Peptide Stimulates GPRC6A-Mediated Response in Leydig and β-Langerhans cell lines.

Authors:  Luca De Toni; Diego Guidolin; Vincenzo De Filippis; Daniele Peterle; Maria Santa Rocca; Andrea Di Nisio; Maurizio De Rocco Ponce; Carlo Foresta
Journal:  Sci Rep       Date:  2019-12-19       Impact factor: 4.379

10.  Observational study on the prognostic value of testosterone and adiposity in postmenopausal estrogen receptor positive breast cancer patients.

Authors:  Elisabetta Venturelli; Annalisa Orenti; Aline S C Fabricio; Giulia Garrone; Roberto Agresti; Biagio Paolini; Chiara Bonini; Massimo Gion; Franco Berrino; Christine Desmedt; Danila Coradini; Elia Biganzoli
Journal:  BMC Cancer       Date:  2018-06-13       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.